Delivery Order SPE2DB20D1100-SPE2DB24FB8C9

Award Date 5/15/24
Potential Completion Date 5/16/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,848.52, is for the delivery of 4565058820 GILENYA 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GILENYA 0.5 MG CAPSULE 30S and other pharmaceutical products and medical supplies. The $11,080.40 contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $25,169.58, is a delivery order for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,939.22 Firm Fixed Price Delivery Order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $9,944.75. It is a firm fixed-price delivery order contract with a performance period through March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract worth $2,936.60 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of April 23, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,657.77 firm fixed price contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with a period of performance through January 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for $3,583.41 to deliver GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has a completion date of July 30, 2024 and is not a set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, with significant Indefinite Delivery Contracts (IDCs) valued at up to $999,999,999 with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $85,579.83 firm fixed-price contract is for the supply of GILENYA 0.5 MG CAPSULE, a pharmaceutical product, with an ultimate completion date of October 25, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB8C9
    Delivery Order

This contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of GILENYA 0.5 MG CAPSULE 30S. The fixed-price delivery order has a completion date of May 16, 2024 and a ceiling value of $18,499.14. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/16/25, 12:21 PM